Truist Financial Cuts Perspective Therapeutics (NYSE:CATX) Price Target to $10.00
Perspective Therapeutics (NYSE:CATX – Free Report) had its target price cut by Truist Financial from $21.00 to $10.00 in a report issued on Monday,Benzinga reports. They currently have a buy rating on the stock. Several other equities analysts also recently weighed in on the stock. Brookline Capital Management raised shares of Perspective Therapeutics to a […]
Perspective Therapeutics (NYSE:CATX – Free Report) had its target price cut by Truist Financial from $21.00 to $10.00 in a report issued on Monday,Benzinga reports. They currently have a buy rating on the stock. Several other equities analysts also recently weighed in on the stock. Brookline Capital Management raised shares of Perspective Therapeutics to a […]
